相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apixaban in a porcine model of mechanical valve thrombosis in pulmonary position-a pilot study
Lucas Van Hoof et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2022)
Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study
Wallis C. Y. Lau et al.
ANNALS OF INTERNAL MEDICINE (2022)
Warfarin and food, herbal or dietary supplement interactions: A systematic review
Christina San San Tan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Aortic Stenosis Progression , Cardiac Damage, and Survival
Li-Tan Yang et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Global epidemiology of valvular heart disease
Sean Coffey et al.
NATURE REVIEWS CARDIOLOGY (2021)
Non-physiologic closing of bi-leaflet mechanical heart prostheses requires a new tri-leaflet valve design
Thierry Carrel et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Rivaroxaban in patients with mechanical heart valves: A pilot study
Eva Roost et al.
THROMBOSIS RESEARCH (2020)
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
Ashley Chen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve
Oliver K. Jawitz et al.
AMERICAN HEART JOURNAL (2020)
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Wonkyung Byon et al.
CLINICAL PHARMACOKINETICS (2019)
A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants
A. T. Cohen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Low-dose anticoagulation after isolated mechanical aortic valve replacement with Liva Nova Bicarbon prosthesis: A post hoc analysis of LOWERING-IT Trial
Michele Torella et al.
SCIENTIFIC REPORTS (2018)
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis
Andre R. Duraes et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Non-Vitamin K Antagonist Oral Anticoagulants for Mechanical Heart Valves Is the Door Still Open?
Alberto Aimo et al.
CIRCULATION (2018)
The Ross procedure is the best operation to treat aortic stenosis in young and middle-aged adults
Maral Ouzounian et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2017)
Dabigatran - Metabolism, Pharmacologic Properties and Drug Interactions
Nebojsa M. Antonijevic et al.
CURRENT DRUG METABOLISM (2017)
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model
Patrick A. Lester et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Edoxaban: A direct oral anticoagulant
Mara Poulakos et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2017)
Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
Clive Kearon et al.
CHEST (2016)
Prosthetic Heart Valve Thrombosis
George D. Dangas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Medical device-induced thrombosis: what causes it and how can we prevent it?
I. H. Jaffer et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation
Iqbal H. Jaffer et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
Agon Mekaj et al.
Therapeutics and Clinical Risk Management (2015)
Anticoagulation Drug Therapy: A Review
Katherine Harter et al.
WESTERN JOURNAL OF EMERGENCY MEDICINE (2015)
Clinical Evaluation of New Heart Valve Prostheses: Update of Objective Performance Criteria
YingXing Wu et al.
ANNALS OF THORACIC SURGERY (2014)
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
N. van Es et al.
BLOOD (2014)
Effectiveness of rivaroxaban for thromboprophylaxis of prosthetic heart valves in a porcine heterotopic valve model
Lawrence E. Greiten et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2014)
Reduced anticoagulation after mechanical aortic valve replacement: Interim results from the Prospective Randomized On-X Valve Anticoagulation Clinical Trial randomized Food and Drug Administration investigational device exemption trial
John Puskas et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
Efficacy and safety of low molecular weight heparin in patients with mechanical heart valves: systematic review and meta-analysis
D. Caldeira et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
Magnus Larsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Gastrointestinal bleeding with the new oral anticoagulants - defining the issues and the management strategies
Jay Desai et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Procoagulant Activity in Hemostasis and Thrombosis: Virchow's Triad Revisited
Alisa S. Wolberg et al.
ANESTHESIA AND ANALGESIA (2012)
Dabigatran versus Warfarin after Mechanical Mitral Valve Replacement in the Swine Model
John L. Schomburg et al.
JOURNAL OF INVESTIGATIVE SURGERY (2012)
Oral Rivaroxaban for Pulmonary Embolism
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Impact of a Pharmacist-Led Warfarin Self-Management Program on Quality of Life and Anticoagulation Control: A Randomized Trial
Lucie Verret et al.
PHARMACOTHERAPY (2012)
Effectiveness of dabigatran etexilate for thromboprophylaxis of mechanical heart valves
Stephen H. McKellar et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
Manesh R. Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Novel Oral Anticoagulants for VTE Prevention in Orthopedic Surgery: Overview of Phase 3 Trials
Richard J. Friedman
ORTHOPEDICS (2011)
Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data
Louis M. Kwong
VASCULAR HEALTH AND RISK MANAGEMENT (2011)
In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves
Lars Maegdefessel et al.
THROMBOSIS RESEARCH (2010)
FLUID MECHANICS OF ARTIFICIAL HEART VALVES
Lakshmi P. Dasi et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends
Jack C. J. Sun et al.
LANCET (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Anatomo-pathological analysis after CoreValve Revalving system implantation
Stephane Noble et al.
EUROINTERVENTION (2009)
Short- and long-term efficacy of aspirin and clopidogrel for thromboprophylaxis for mechanical heart valves: An in vivo study in swine
Stephen H. McKellar et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2008)
A model of heterotopic aortic valve replacement for studying thromboembolism prophylaxis in mechanical valve prostheses
Stephen H. McKellar et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Valve disease - Thrombosis of prosthetic heart valves: Diagnosis and therapeutic considerations
Raymond Roudaut et al.
HEART (2007)
Management and follow up of prosthetic heart valves
C Seiler
HEART (2004)
The initial experience with the ATS medical mechanical cardiac valve prosthesis
RW Emery et al.
ANNALS OF THORACIC SURGERY (2003)
分享论文
